Vitamin D status and COVID-19 severity

Southern African Journal of Infectious Diseases

 
 
Field Value
 
Title Vitamin D status and COVID-19 severity
 
Creator Kalichuran, Senrina van Blydenstein, Sarah A. Venter, Michelle Omar, Shahed
 
Subject Internal medicine; infectious diseases vitamin D; COVID-19; severity; Johannesburg; South Africa
Description Background: Age, body mass index (BMI) and pre-existing comorbidities are known risk factors of severe coronavirus disease 2019 (COVID-19). In this study we explore the relationship between vitamin D status and COVID-19 severity.Methods: We conducted a prospective, cross-sectional descriptive study. We enrolled 100 COVID-19 positive patients admitted to a tertiary level hospital in Johannesburg, South Africa. Fifty had symptomatic disease (COVID-19 pneumonia) and 50 who were asymptomatic (incidental diagnosis). Following written informed consent, patients were interviewed regarding age, gender and sunlight exposure during the past week, disease severity, BMI, calcium, albumin, magnesium and alkaline phosphatase levels. Finally, blood was collected for vitamin D measurement.Results: We found an 82% prevalence rate of vitamin D deficiency or insufficiency among COVID-19 patients. Vitamin D levels were lower in the symptomatic group (18.1 ng/mL ± 8.1 ng/mL) than the asymptomatic group (25.9 ng/mL ± 7.1 ng/mL) with a p-value of 0.000. The relative risk of symptomatic COVID-19 was 2.5-fold higher among vitamin D deficient patients than vitamin D non-deficient patients (confidence interval [CI]: 1.14–3.26). Additional predictors of symptomatic disease were older age, hypocalcaemia and hypoalbuminaemia. Using multiple regression, the only independent predictors of COVID-19 severity were age and vitamin D levels. The patients exposed to less sunlight had a 2.39-fold increased risk for symptomatic disease compared to those with more sunlight exposure (CI: 1.32–4.33).Conclusion: We found a high prevalence of vitamin D deficiency and insufficiency among patients admitted to hospital with COVID-19 and an increased risk for symptomatic disease in vitamin D deficient patients. 
 
Publisher AOSIS Publishing
 
Contributor The University of the Witwatersrand Internal Medicine fund, RINC (research publication incentive)
Date 2022-04-26
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — prospective; cross-sectional; descriptive
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajid.v37i1.359
 
Source Southern African Journal of Infectious Diseases; Vol 37, No 1 (2022); 6 pages 2313-1810 2312-0053
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajid.co.za/index.php/sajid/article/view/359/946 https://sajid.co.za/index.php/sajid/article/view/359/947 https://sajid.co.za/index.php/sajid/article/view/359/948 https://sajid.co.za/index.php/sajid/article/view/359/949
 
Coverage Johannesburg; South Africa — —
Rights Copyright (c) 2022 Senrina Kalichuran https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT